Showing results (31-40 of 238) with videos related to
Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastasesRichard J Lee, Philip J Saylor, M Dror Michaelson, et al.Breast Cancer Research and Treatment|June 8, 2021
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNATilak K Sundaresan, Taronish D Dubash, Zongli Zheng, et al.Science (New York, N.Y.)|January 15, 2011
Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancersDavid T Ting, Doron Lipson, Suchismita Paul, et al.Biomaterials|July 6, 2015
Biodegradable nano-films for capture and non-invasive release of circulating tumor cellsWei Li, Eduardo Reátegui, Myoung-Hwan Park, et al.Proceedings of the National Academy of Sciences of the United States of America|December 13, 2003
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107Thanh U Barbie, David A Barbie, David T MacLaughlin, et al.Nature|December 22, 2007
Isolation of rare circulating tumour cells in cancer patients by microchip technologySunitha Nagrath, Lecia V Sequist, Shyamala Maheswaran, et al.Cancer Research|June 17, 2006
Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processingSven Diederichs, Daniel A HaberCell|December 18, 2007
Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expressionSven Diederichs, Daniel A HaberBreast Cancer Research : BCR|June 10, 2003
Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer riskJenny Varley, Daniel A HaberCell Cycle (Georgetown, Tex.)|June 23, 2005
Overcoming acquired resistance to Iressa/Tarceva with inhibitors of a different classDaniel A Haber, Jeffrey SettlemanPageof 24